Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids
- 17 August 2012
- journal article
- review article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 106 (11), 1487-1493
- https://doi.org/10.1016/j.rmed.2012.07.011
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 10 references indexed in Scilit:
- Inhaled Corticosteroids and the Risks of Diabetes Onset and ProgressionAmerican Journal Of Medicine, 2010
- The Association of Inhaled Corticosteroid Use with Serum Glucose Concentration in a Large CohortAmerican Journal Of Medicine, 2009
- The Effect of an Inhaled Corticosteroid on Glucose Control in Type 2 DiabetesClinical Medicine & Research, 2009
- Global strategy for asthma management and prevention: GINA executive summaryEuropean Respiratory Journal, 2008
- Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007Journal of Allergy and Clinical Immunology, 2007
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trialThe Lancet, 2003
- Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderlyJournal of General Internal Medicine, 2002
- Inhaled corticosteroids and the risk of diabetes among the elderlyBritish Journal of Clinical Pharmacology, 2002